Kimberley Elting - Orthofix Medical President Orthopedics
| OFIX Stock | USD 12.99 0.11 0.84% |
President
Ms. Kimberley A. Elting is Chief Legal and Administrative Officer of the Company. She joined Orthofix as Chief Legal Officer in September 2016 and was named Chief Legal and Administrative Officer in 2017. Before joining the Company, she had served since 2013 as General Counsel and Vice President Corporationrationrate Affairs at TriVascular Technologies, Inc. In this role, she led the legal, compliance, human resources and government affairs functions. Between 2007 and 2012, she served in various roles of increasing responsibility with St. Jude Medical, including General Counsel and Vice President of HR and Health Policy for the Neuromodulation Division. She also previously was a partner at the Jones Day law firm where she counseled clients in the health care sector on mergers and acquisitions and regulatory matters. A graduate of Ithaca College, Ms. Elting earned her Law Degree from the University of Denver and an LL.M. in Health Law from Loyola University Chicago. since 2017.
| Age | 59 |
| Tenure | 7 years |
| Address | 3451 Plano Parkway, Lewisville, TX, United States, 75056 |
| Phone | 214 937 2000 |
| Web | https://www.orthofix.com |
Orthofix Medical Management Efficiency
The company has return on total asset (ROA) of (0.063) % which means that it has lost $0.063 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3236) %, meaning that it created substantial loss on money invested by shareholders. Orthofix Medical's management efficiency ratios could be used to measure how well Orthofix Medical manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to -0.23 in 2024. Return On Capital Employed is likely to rise to -0.18 in 2024. At this time, Orthofix Medical's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 530.1 M in 2024, whereas Other Current Assets are likely to drop slightly above 20.9 M in 2024.Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Joseph Sowell | HCA Holdings | 64 | |
| Charles Gressle | HCA Holdings | N/A | |
| Troy Villarreal | HCA Holdings | N/A | |
| Deborah Reiner | HCA Holdings | 62 | |
| Dan Miller | HCA Holdings | N/A | |
| Greg Lowe | HCA Holdings | N/A | |
| Joseph Steakley | HCA Holdings | 62 | |
| Jon Foster | HCA Holdings | 62 | |
| Shane Brinkerhoff | Aveanna Healthcare Holdings | N/A | |
| Brian Cook | HCA Holdings | N/A | |
| William Morrow | HCA Holdings | 48 | |
| Robert Oliva | Novo Integrated Sciences | 60 | |
| Tim McManus | HCA Holdings | N/A | |
| William Rutherford | HCA Holdings | 60 | |
| Ravi Chari | HCA Holdings | 51 | |
| Christopher David | Novo Integrated Sciences | 65 | |
| John Hollinsworth | Acadia Healthcare | 60 | |
| Paul Paslick | HCA Holdings | 61 | |
| Jane Englebright | HCA Holdings | 62 | |
| John Steele | HCA Holdings | 62 | |
| Brent Turner | Acadia Healthcare | 52 | |
Management Performance
| Return On Equity | -0.32 | ||||
| Return On Asset | -0.063 |
Orthofix Medical Leadership Team
Elected by the shareholders, the Orthofix Medical's board of directors comprises two types of representatives: Orthofix Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Orthofix. The board's role is to monitor Orthofix Medical's management team and ensure that shareholders' interests are well served. Orthofix Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Orthofix Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michael Paolucci, Independent Director | ||
| Rice Doug, CFO | ||
| Doug Rice, Interim CFO, Chief Accounting Officer | ||
| Lucas Vitale, Chief Officer | ||
| Frank Vizesi, Chief Officer | ||
| Julie Andrews, Chief Officer | ||
| Roberto Donadello, Senior Operations | ||
| Jeffrey Schumm, Chief Admin. Officer, General Counsel and Corporate Secretary | ||
| Mark Quick, Sr Relations | ||
| Tyler Lipschultz, President Biologics | ||
| Dan Yarbrough, Vice Relations | ||
| James Hinrichs, Independent Director | ||
| BA Chemistry, Chief Officer | ||
| Kimberley Elting, President Orthopedics | ||
| Bradley Mason, CEO and President and Director | ||
| Robert Goodwin, President - Biologics | ||
| Alexis Lukianov, Independent Director | ||
| Raymond Fujikawa, President - Spine Fixation | ||
| Davide Bianchi, President of Global Extremity Fixation | ||
| Anthony Martin, Independent Director | ||
| Ehab Esmail, Regulatory Quality | ||
| Guy Jordan, Independent Director | ||
| Suzanne Armstrong, Chief Officer | ||
| Bradley Niemann, President - BioStim | ||
| Douglas Rice, CFO Officer | ||
| Jon Serbousek, President - Global Spine Business | ||
| Jill Mason, Interim Counsel | ||
| Michael Finegan, Chief Strategy Officer | ||
| Ronald Matricaria, Independent Chairman of the Board | ||
| Maria Sainz, Independent Director | ||
| Lilly Marks, Director | ||
| Kevin Kenny, President Business | ||
| John Sicard, Independent Director | ||
| Luke Faulstick, Director | ||
| Massimo Calafiore, CEO President |
Orthofix Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Orthofix Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.32 | ||||
| Return On Asset | -0.063 | ||||
| Profit Margin | (0.20) % | ||||
| Operating Margin | (0.02) % | ||||
| Current Valuation | 587 M | ||||
| Shares Outstanding | 37.41 M | ||||
| Shares Owned By Insiders | 3.52 % | ||||
| Shares Owned By Institutions | 96.25 % | ||||
| Number Of Shares Shorted | 3.78 M | ||||
| Price To Earning | 338.00 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Orthofix Medical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Orthofix Medical's short interest history, or implied volatility extrapolated from Orthofix Medical options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Orthofix Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Orthofix Stock please use our How to Invest in Orthofix Medical guide.You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Complementary Tools for Orthofix Stock analysis
When running Orthofix Medical's price analysis, check to measure Orthofix Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orthofix Medical is operating at the current time. Most of Orthofix Medical's value examination focuses on studying past and present price action to predict the probability of Orthofix Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orthofix Medical's price. Additionally, you may evaluate how the addition of Orthofix Medical to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |
Is Orthofix Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Orthofix Medical. If investors know Orthofix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Orthofix Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.12) | Revenue Per Share 20.328 | Quarterly Revenue Growth 0.64 | Return On Assets (0.06) | Return On Equity (0.32) |
The market value of Orthofix Medical is measured differently than its book value, which is the value of Orthofix that is recorded on the company's balance sheet. Investors also form their own opinion of Orthofix Medical's value that differs from its market value or its book value, called intrinsic value, which is Orthofix Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Orthofix Medical's market value can be influenced by many factors that don't directly affect Orthofix Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Orthofix Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Orthofix Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Orthofix Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.